Cristina Müller - Search Results

Year	Number of Results
2002	1
2006	5
2007	3
2008	3
2009	3
2010	6
2011	5
2012	7
2013	14
2014	10
2015	7
2016	10
2017	14
2018	10
2019	15
2020	15
2021	13
2022	8
2023	7
2024	5

1

Theranostics - a sure cure for cancer after 100 years?

Song Y, Zou J, Castellanos EA, Matsuura N, Ronald JA, Shuhendler A, Weber WA, Gilad AA, Müller C, Witney TH, Chen X. Song Y, et al. Among authors: muller c. Theranostics. 2024 Mar 31;14(6):2464-2488. doi: 10.7150/thno.96675. eCollection 2024. Theranostics. 2024. PMID: 38646648 Free PMC article. Review.

2

Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.

Vaccarin C, Mapanao AK, Deberle LM, Becker AE, Borgna F, Marzaro G, Schibli R, Müller C. Vaccarin C, et al. Among authors: muller c. Cancers (Basel). 2024 Mar 23;16(7):1262. doi: 10.3390/cancers16071262. Cancers (Basel). 2024. PMID: 38610940 Free PMC article.

3

Liquid Chromatography ICP-MS to Assess the Stability of ¹⁷⁵Lu- and ^natGa-Based Tumor-Targeting Agents towards the Development of ¹⁷⁷Lu- and ⁶⁸Ga-Labeled Radiopharmaceuticals.

Wallimann RH, Hensinger H, Müller C, Schibli R, Kneuer R, Schindler P. Wallimann RH, et al. Among authors: muller c. Pharmaceutics. 2024 Feb 21;16(3):299. doi: 10.3390/pharmaceutics16030299. Pharmaceutics. 2024. PMID: 38543193 Free PMC article.

4

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.

Fricke J, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas GP, Geistlich S, Borgna F, Fani M, Bernhardt P, van der Meulen NP, Müller C, Schibli R, Wild D. Fricke J, et al. Among authors: muller c. Eur J Nucl Med Mol Imaging. 2024 Mar 7. doi: 10.1007/s00259-024-06641-w. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38448550 No abstract available.

5

Prostate-Specific Membrane Antigen-Targeted Therapies for Prostate Cancer: Towards Improving Therapeutic Outcomes.

Corpetti M, Müller C, Beltran H, de Bono J, Theurillat JP. Corpetti M, et al. Among authors: muller c. Eur Urol. 2024 Mar;85(3):193-204. doi: 10.1016/j.eururo.2023.11.018. Epub 2023 Dec 16. Eur Urol. 2024. PMID: 38104015 Review.

6

Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates.

Busslinger SD, Becker AE, Vaccarin C, Deberle LM, Renz ML, Groehn V, Schibli R, Müller C. Busslinger SD, et al. Among authors: muller c. Cancers (Basel). 2023 Aug 25;15(17):4259. doi: 10.3390/cancers15174259. Cancers (Basel). 2023. PMID: 37686538 Free PMC article.

7

Albumin-Binding and Conventional PSMA Ligands in Combination with ¹⁶¹Tb: Biodistribution, Dosimetry, and Preclinical Therapy.

Tschan VJ, Busslinger SD, Bernhardt P, Grundler PV, Zeevaart JR, Köster U, van der Meulen NP, Schibli R, Müller C. Tschan VJ, et al. Among authors: muller c. J Nucl Med. 2023 Oct;64(10):1625-1631. doi: 10.2967/jnumed.123.265524. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442604

8

Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics.

Müller C, van der Meulen NP, Schibli R. Müller C, et al. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3181-3184. doi: 10.1007/s00259-023-06316-y. Eur J Nucl Med Mol Imaging. 2023. PMID: 37436459 No abstract available.

9

¹⁶¹Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of ¹⁶¹Tb into the Clinic.

Favaretto C, Grundler PV, Talip Z, Landolt S, Sepini L, Köster U, Müller C, Schibli R, Geistlich S, van der Meulen NP. Favaretto C, et al. Among authors: muller c. J Nucl Med. 2023 Jul;64(7):1138-1144. doi: 10.2967/jnumed.122.265268. Epub 2023 May 18. J Nucl Med. 2023. PMID: 37201956 Free PMC article.

10

A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides.

Beyer D, Vaccarin C, Deupi X, Mapanao AK, Cohrs S, Sozzi-Guo F, Grundler PV, van der Meulen NP, Wang J, Tanriver M, Bode JW, Schibli R, Müller C. Beyer D, et al. Among authors: muller c. EJNMMI Res. 2023 Apr 19;13(1):32. doi: 10.1186/s13550-023-00979-2. EJNMMI Res. 2023. PMID: 37074529 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year